Capricor Therapeutics (CAPR) Debt Ratio (2010 - 2024)

Capricor Therapeutics' Debt Ratio history runs 15 years deep, the most recent figure standing at 0.04 for Q3 2024.

• On a quarterly basis, Debt Ratio fell 60.03% year-over-year to 0.04 in Q3 2024; TTM through Sep 2024 was 0.04, a 60.03% decrease from a year earlier, with the FY2023 full-year figure at 0.06, down 16.91% from the prior year.
• Debt Ratio slipped to 0.04 in Q3 2024 per CAPR's latest filing, from 0.09 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.24 in Q1 2020 and bottomed at 0.0 in Q1 2021.
• The 5-year median for Debt Ratio is 0.06 (2022), against an average of 0.07.
• Across the five-year window, Debt Ratio slumped 99.66% in 2021 and jumped 7371.55% in 2022, its largest moves.
• Year by year, Debt Ratio stood at 0.0 in 2020, then surged by 4559.3% to 0.1 in 2021, then retreated by 28.08% to 0.07 in 2022, then retreated by 16.91% to 0.06 in 2023, then plunged by 36.81% to 0.04 in 2024.
• Per Business Quant, the three latest CAPR Debt Ratio figures stand at 0.04 (Q3 2024), 0.09 (Q2 2024), and 0.07 (Q1 2024).